# ERAXIS
> **NDA021632** · New Drug Application · Sponsor: VICURON HOLDINGS · Approved 2006-02-17
## Drug
- **FDA Application Number:** NDA021632
- **Application type:** New Drug Application
- **Brand name:** ERAXIS
- **Generic name:** ANIDULAFUNGIN
- **Active ingredients:** ANIDULAFUNGIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** VICURON HOLDINGS
- **Manufacturer:** Roerig
- **First approval:** 2006-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021632)
---
*MORVS · CC0 1.0*